Global Substance Abuse Treatment Market Research Report to 2027 – Emerging Number of Treatment Centers With Partnerships With Private Recovery Facilities Presents Opportunities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Substance Abuse Treatment Market Research Report by Treatment, by Product, by Distribution Channel, by Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering.

The Global Substance Abuse Treatment Market size was estimated at USD 4,681.47 million in 2020, is expected to reach USD 5,089.69 million in 2021, and is projected to grow at a CAGR of 9.08% to reach USD 8,605.25 million by 2027.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Substance Abuse Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Substance Abuse Treatment Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Substance Abuse Treatment Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Substance Abuse Treatment Market?

4. What is the competitive strategic window for opportunities in the Global Substance Abuse Treatment Market?

5. What are the technology trends and regulatory frameworks in the Global Substance Abuse Treatment Market?

6. What is the market share of the leading vendors in the Global Substance Abuse Treatment Market?

7. What modes and strategic moves are considered suitable for entering the Global Substance Abuse Treatment Market?

Market Dynamics

Drivers

• Growing cases of tobacco addiction across the globe
• Increasing patient awareness and higher treatment seeking rate
• Favorable efforts from the governments to curb the use of these substances

Restraints

• Relatively high cost of the treatment and poor treatment compliance

Opportunities

• Emerging number of treatment centers with partnerships with private recovery facilities
• Growing introduction of new products and therapy coupled with better reimbursement options

Challenges

• Increasing cases of discontinuation of behavioral therapies and patients opt for outpatient care

Companies Mentioned

• AbbVie Inc.
• Accord Healthcare Limited
• Alkermes PLC
• Amphastar Pharmaceuticals, Inc.
• BioCorRx, Inc.
• Cipla Limited
• Dr. Reddy’s Laboratories Ltd.
• Elite Pharmaceuticals, Inc.
• GlaxoSmithKline PLC
• Glenmark Pharmaceuticals Limited
• Indivior
• LFB Group
• Mallinckrodt LLC
• Novartis International AG
• Pfizer Inc.
• Purdue Pharma L.P.
• Reckitt Benckiser Group PLC
• Sanofi S.A.
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.

For more information about this report visit https://www.researchandmarkets.com/r/ho7jz2

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900